Dr. Michael Z. Moore, MD
Neurology (Neurology Physician)
- Medicare participating
At a glance
- Years since graduation
- 8
- In the NPI registry since
- 2018
- Medicare patients seen, 2024
- 67
Licensed in Texas since 2023, according to the Texas Medical Board. We show license dates only for the states that publish them in bulk; see which states do. For other states, check the state medical board.
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. What an NPI is
Education and training
- 2018Registered with an NPI (national billing number; not a license date)
Medicare’s Care Compare data doesn’t list this clinician’s medical school. Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Neurology Physician primary
TX license U6535 (first issued 2023; active) -
Psychiatry Physician
TX license U6535 (first issued 2023; active)
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Harris Health Houston, TX
- Baylor St Lukes Medical Center Houston, TX
Medical groups
- Baylor College of Medicine (1,240 clinicians)
- Baylor College of Medicine (809 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 67
- Services billed
- 2,358
- Patients’ average age
- 65
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Gabapentin Other prescribers in Houston, TX | 40 |
| Baclofen Other prescribers in Houston, TX | 32 |
| Dalfampridine Er (dalfampridine) | 31 |
| Teriflunomide | 24 |
| Pregabalin Other prescribers in Houston, TX | 24 |
| Kesimpta Pen (ofatumumab) | 18 |
| Oxybutynin Chloride Er (oxybutynin chloride) Other prescribers in Houston, TX | 14 |
| Duloxetine Hcl Other prescribers in Houston, TX | 13 |
| Lacosamide Other prescribers in Houston, TX | 12 |
| Tizanidine Hcl Other prescribers in Houston, TX | 11 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 1 companies reported 2 payments worth $111 in total to this clinician.
| EMD Serono, Inc. | $111 |
|---|
| Education | $111 |
|---|
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| EMD Serono, Inc. Nov 9, 2025 | Education in-kind Company’s descriptionReprints | $55.50 |
| EMD Serono, Inc. Nov 9, 2025 | Education in-kind Company’s descriptionReprints | $55.50 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 1 industry-funded study in 2025, from 1 company. The companies reported $8,406 in research payments for these studies, mostly to the institutions running them.
- A Long-Term, Prospective, Observational, Registry of Patients with Anti-Aquaporin 4 Antibody-Positive (AQP4+) Neuromyelitis Optica Spectrum Disorder (NMOSD) Treated with Alexion Complement Component 5 (C5) Inhibitor T…
Alexion Pharmaceuticals, Inc.
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.